Ultrasound May Be Unreliable in Spotting Endometrial Cancer in Black Women

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on July 2, 2024.

By Dennis Thompson HealthDay Reporter

TUESDAY, July 2, 2024 -- Ultrasound cannot reliably rule out endometrial cancer in Black women given how readings are now assessed, a new study argues.

Transvaginal ultrasound is commonly used to screen for cancer by measuring the thickness of the endometrium, the inner wall of the uterus.

This screening method is supposed to be 99% to 100% accurate for ruling out endometrial cancer, researchers said. An endometrium thinner than 4 millimeters is considered normal; thicker readings typically trigger a biopsy to check for cancer.

But that protocol can be deadly for Black women, study results show.

Nearly 10% of Black women with endometrial cancer had thickness below 4 millimeters, researchers found by analyzing 1,500 Black patients who underwent hysterectomies at 10 hospitals.

“We found that 9.5% of the cancers in Black women were detected below the threshold of 4 millimeters, and 11.5% of the cancers would have been missed at 5 millimeters,” lead researcher Dr. Kemi Doll, a gynecologic oncologist at the University of Washington, said in a news release.

“This is just not acceptable,” Doll said of the current standards for ultrasound screening. “What we found in real-world clinical scenarios, is that it’s just not accurate enough to be safely employed as a strategy among Black people. Whereas, a tissue biopsy is conclusive.”

In an ultrasound screening, a probe is inserted into the vagina that produces sound waves. By moving it around, technicians can capture images of reproductive structures like the uterus, ovaries and fallopian tubes.

The diagnostic protocols set for ultrasound cancer screening are established for the general population, Doll said.

But in Black women, four complicating factors make it more difficult to screen for endometrial cancer using ultrasound, she said:

  • Decreased visibility of the cancers.

  • Increased presence of non-cancerous fibroids, which can distort the quality of the images.

  • Larger body size.

  • The skill of the technician performing the scan.

    • “You might have a cancerous lesion in one area, but not another, but if you don’t look in that specific area, you might assume (the patient) is cancer free,” Doll said.

    These results show that technicians and doctors “need to do more” to screen for endometrial cancer in Black women, she said.

    For Black women, a tissue sample should be the first test for cancer, rather than an optional follow-up to ultrasound, Doll said.

    The findings were published June 27 in JAMA Oncology.

    Sources

  • University of Washington, news release, June 27, 2024

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2024-07-03 03:15

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords